News Notification

The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology 2025

30 views Tags: CME Brigham Board Review

Master Hematology CME

Gain essential knowledge with The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology online CME program. This expert-led course covers key topics such as molecular genetics, leukemia, lymphomas, and bone marrow disorders, helping you refine patient care strategies and excel on your board exam. Continuing medical education areas for practice improvement include:

  • Hematopoiesis and Cytokines
  • Immune and Non-immune Hemolytic Anemia
  • Molecular Genetics of Cancer
  • Thalassemia and Other Hemoglobinopathies
  • Acquired Thrombocytopenias
  • Von Willebrand Disease and Congenital Platelet Disorders
  • Transfusion Medicine
  • and many more…

* Date of Original Release: March 15, 2025

LEARNING OBJECTIVES

At the conclusion of this activity, the participant will be able to:

  • Apply current/recommended hematology guidelines in clinical practice
  • Perform differential diagnosis of complex clinical presentations related to hematologic disorders
  • Identify/apply current therapeutic options for specific hematologic disorders
  • Review and interpret up-to-date literature relevant to clinical practice in hematology
  • Demonstrate knowledge of pathophysiology as it applies to the management of hematology disorders
  • Apply knowledge gained to the ABIM certification/recertification hematology examinations

THE BRIGHAM AND DANA-FARBER BOARD REVIEW IN HEMATOLOGY 2025

0 0 votes
Article Rating

THE BRIGHAM AND DANA-FARBER BOARD REVIEW IN HEMATOLOGY 2025 TOPICS

1. Molecular Genetics of Cancer – Marios Giannakis, MD, PhD

2. Infections in Cancer Patients – Lindsey Baden, MD

3. Opioid Prescribing for Cancer-Related Pain – Kate M. Lally, MD

4. Communication – The Key to Excellence in End-of-Life Care – Eilann C. Santo, MD, MPH

5. Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD

6. Biology of Acute Leukemia and Myelodysplastic Syndromes – Zuzana Tothova, MD, PhD

7. The Evolving Treatment Landscape of the Acute Leukemias – Where Are We Now – Daniel J. DeAngelo, MD, PhD

8. Myelodysplastic Syndrome – Eric S. Winer, MD

9. Chronic Myelogenous Leukemia – Marlise R. Luskin, MD

10. Myeloproliferative Syndromes – Joan-Chi How, MD

11. Multiple Myeloma – Kenneth C. Anderson, MD

12. Waldenstrom Macroglobulinemia and Amyloidosis – Jorge J. Castillo, MD

13. Low Grade Lymphomas – Caron A. Jacobson, MD

14. Agressive Non-Hodgkin Lymphoma Part 1 – Diffuse Large B-Cell and Burkitt – Eric D. Jacobsen, MD

15. Agressive Non-Hodgkin Lymphoma Part 2 – Mantle Cell and T-Cell – Eric D. Jacobsen, MD

16. Hodgkin’s Lymphoma – Reid W. Merryman, MD

17. Diagnosis and Treatment of CLL and Related B-Cell Malignancies – Matthew S. Davids, MD

18. Hematopoiesis and Cytokines – David B. Sykes, MD, PhD

19. Acquired Bone Marrow Failure – Julie-Aurore Losman, MD, PhD

20. Congenital Bone Marrow Failure – Grant Rowe, MD, PhD

21. HLH – Sarah Nikiforow, MD

22. Anemia – An Overview – Robert Stern, MD

23. Iron Deficiency and Iron Overload – Mark D. Fleming, MD, DPhil

24. Immune Hemolytic Anemia – Arielle L. Langer, MD, MPH

25. Non-immune Hemolytic Anemia – David E. Golan, PhD, MD

26. Sickle Cell Disease – Maureen M. Achebe, MD, MPH

27. Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD

28. Disorders of Neutrophils – Nancy Berliner, MD

29. Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD

30. Hemophilia – Stacy E. Croteau, MD

31. Von Willebrand Disease and Congenital Platelet Disorders – Nathan T. Connell, MD, MPH

32. Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD

33. Managing Challenging Cases of Venous Thrombosis in Patients with Cancer – Jean M. Connors, MD

34. Transfusion Medicine for the Clinician – Marie A. Hollenhorst, MD, PhD

Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
error: Content is protected !!